Wen, X., Wan, J., He, Q., Wang, M., Li, S., Jiang, M., . . . Wan, X. (2020). p190A inactivating mutations cause aberrant RhoA activation and promote malignant transformation via the Hippo-YAP pathway in endometrial cancer. Signal Transduct Target Ther.
Chicago-stil citatWen, Xiaoli, et al. "P190A Inactivating Mutations Cause Aberrant RhoA Activation and Promote Malignant Transformation Via the Hippo-YAP Pathway in Endometrial Cancer." Signal Transduct Target Ther 2020.
MLA-referensWen, Xiaoli, et al. "P190A Inactivating Mutations Cause Aberrant RhoA Activation and Promote Malignant Transformation Via the Hippo-YAP Pathway in Endometrial Cancer." Signal Transduct Target Ther 2020.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.